SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-735728
Filing Date
2016-10-11
Accepted
2016-10-11 16:20:03
Documents
2
Period of Report
2016-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d248373d8k.htm 8-K 19317
2 EX-10.1 d248373dex101.htm EX-10.1 28162
  Complete submission text file 0001193125-16-735728.txt   48972
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25571 | Film No.: 161931300
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences